REQUEST A DEMO
Total
USD $0.00
Search more companies

Aptamer Sciences Inc. (South Korea)

Main Activities: Research and Development in Nanotechnology
Full name: Aptamer Sciences Inc. Profile Updated: June 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Aptamer Sciences Inc. is a firm based in Seongnam, South Korea, specializing in healthcare and biotechnology research. The company offers a range of products and services in biotechnology, life sciences, drug discovery, biopharmaceuticals, bioinformatics, pharmaceuticals, and orphan drugs. With a team of 11-50 employees, Aptamer Sciences Inc. was established in 2011 by researchers from POSTECH BIOTECH CENTER in Pohang, South Korea. The company focuses on commercializing advanced technologies for protein analysis, utilizing its proprietary aptamer technology platforms. Aptamer Sciences Inc. has developed innovative aptamer technologies that enable more efficient generation of aptamers with superior binding affinity. The company is committed to further developing these technologies for the production of high-quality aptamers and their broad applications in research, diagnosis, and therapeutics.

Headquarters
3-301, (Sampyeong-Dong Pangyo Seven Venture Valley1), 15, Pangyo-Ro 228Beon-Gil, Bundang-Gu
Seongnam; Gyeonggi;

Contact Details: Purchase the Aptamer Sciences Inc. report to view the information.

Website: http://www.aptsci.com

Basic Information
Total Employees:
Purchase the Aptamer Sciences Inc. report to view the information.
Outstanding Shares:
Purchase the Aptamer Sciences Inc. report to view the information.
Registered Capital:
Purchase the Aptamer Sciences Inc. report to view the information.
Financial Auditors:
Purchase the Aptamer Sciences Inc. report to view the information.
Incorporation Date:
April 01, 2011
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜압타머사이언스
Company Performance
Financial values in the chart are available after Aptamer Sciences Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
1056.55%
Total operating revenue
1056.5%
Operating Profit/Loss (EBIT)
-0.89%
EBITDA
7.75%
Net Profit/Loss for the Period
9.25%
Total Assets
-3.82%
Total Equity
76.99%
Operating Profit Margin (ROS)
3932.67%
Net Profit Margin
4313.7%
Return on Equity (ROE)
9.01%
Debt/Equity
-59.62%
Quick Ratio
2.99%
Cash Ratio
4.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?